Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of reteplase for acute iliofemoral deep vein thrombosis in adults
CTR20213141Phase 2Active
- Sponsor
- China Resources Angde Biopharmaceutical
- Start
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of reteplase in deep vein thrombosis (DVT), sponsored by China Resources Angde Biopharmaceutical. Started Dec 2021; status: active.
02
Drugs
reteplase
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on CTR20213141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213141.